Non-Current Assets

Derivative Assets, Non-Current

Pfizer Derivative Assets, Non-Current increased by 33.6% to $155.00M in Q1 2026 compared to the prior quarter.

Analysis

StatementBalance Sheet Statement
SectionNon-Current Assets
CategoryRisk
SignalContext dependent
VolatilityVolatile
First reportedQ4 2025
Last reportedQ1 2026May 5, 2026

How to read this metric

An increase reflects long-term favorable hedging positions, while a decrease indicates a reduction in the value of long-dated hedges.

Detailed definition

This represents the fair value of derivative financial instruments in an asset position that are expected to be settled...

Peer comparison

Common in regulated utilities with long-term fuel procurement or interest rate hedging programs.

Metric ID: derivative_assets_noncurrent

Historical Data

2 periods
 Q4 '25Q1 '26
Value$116.00M$155.00M
QoQ Change—+33.6%
Range$116.00M – $155.00M

Derivative Assets, Non-Current at Other Companies

TRG
Targa ResourcesTRGPView metric
TRG
Targa ResourcesTRGPView metric
Atmos Energy logo
Atmos EnergyATOView metric
TRG
Targa ResourcesTRGPView metric
Atmos Energy logo
Atmos EnergyATOView metric
Edison International logo
Edison InternationalEIXView metric

Frequently Asked Questions

What is Pfizer's derivative assets, non-current?
Pfizer (PFE) reported derivative assets, non-current of $155.00M in Q1 2026.
What does derivative assets, non-current mean?
The value of long-term financial hedging contracts that are currently in a gain position.